Xi-yu Wang
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Platelet-Derived Growth Factor C Facilitates Malignant Behavior of Pancreatic Ductal Adenocarcinoma by Regulating SREBP1 Mediated Lipid Metabolism.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 25, 2024
N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance.
Journal: Oncogene
Published: December 19, 2023
CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy.
Journal: Cancer letters
Published: August 28, 2023
Learning curves of resection and reconstruction procedures in robotic-assisted pancreatoduodenectomy by a single surgeon: a retrospective cohort study of 160 consecutive cases.
Journal: Gastroenterology report
Published: April 30, 2023
SUMO specific peptidase 3 halts pancreatic ductal adenocarcinoma metastasis via deSUMOylating DKC1.
Journal: Cell death and differentiation
Published: December 07, 2022
Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 17, 2022
Identification of Genomic Alterations in Sporadic Pancreatic Neurogenic Tumors.
Journal: Pancreas
Published: October 30, 2020
Impact of enhanced recovery after surgery protocol on pancreaticoduodenectomy: a meta-analysis of non-randomized and randomized controlled trials.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: December 25, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026